Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.41 -0.15 (-9.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cardiol Therapeutics (CRDL) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Cardiol Therapeutics' Return on Capital Employed [ROCE] came in at -142.26% for Q2 2026, up 139.32 percentage points from -281.58% a year earlier and up 32.81 percentage points from the prior quarter.

Analysis

Cardiol Therapeutics (CRDL) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Cardiol Therapeutics' Return on Capital Employed [ROCE] was -153.11%, down 5.98 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined in each of the last three years, with a four-year change of -55.97 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -147.12% in FY2024 (-74.76 pp), -72.36% in FY2023 (-12.28 pp), -60.08% in FY2022 (+37.05 pp) and -97.13% in FY2021.
  • The Q2 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] since Q1 2024.
  • Year-over-year, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -46.57 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2026 (a gain of 139.32 percentage points), and the weakest in Q3 2024 (a drop of 174.55 percentage points).
  • Business Quant data shows CRDL's Return on Capital Employed [ROCE] at -175.06% (Q1 2026), -269.48% (Q4 2025) and -273.05% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Cardiol Therapeutics 156.40 Mn 156.40 Mn - -142.26%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -142.26%
Mar 31, 2026 -175.06%
Dec 31, 2025 -269.48%
Sep 30, 2025 -273.05%
Jun 30, 2025 -281.58%
Mar 31, 2025 -195.32%
Dec 31, 2024 -229.65%
Sep 30, 2024 -257.35%
Jun 30, 2024 -177.19%
Mar 31, 2024 -133.20%
Dec 31, 2023 -94.14%
Sep 30, 2023 -82.79%
Jun 30, 2023 -88.70%
Mar 31, 2023 -80.50%
Dec 31, 2022 -76.03%
Sep 30, 2022 -74.05%
Jun 30, 2022 -64.84%
Mar 31, 2022 -53.99%
Dec 31, 2021 -80.41%
Sep 30, 2021 -108.87%
API Access

Cardiol Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CRDL&period=max&api_key=YOUR_API_KEY